Frommeyer G, Eckardt L. Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms. Nat Rev Cardiol. 2016;13(1):36–47.
Article CAS PubMed Google Scholar
Tisdale JE, Chung MK, Campbell KB, et al. Drug-induced arrhythmias: a scientific statement from the American heart association. Circulation. 2020;142(15):e214–33.
Shah RR. Drugs, QTc interval prolongation and final ICH E14 guideline: an important milestone with challenges ahead. Drug Saf. 2005;28(11):1009–28.
Article CAS PubMed Google Scholar
Shah RR. If a drug deemed “safe” in nonclinical tests subsequently prolongs QT in phase 1 studies, how can its sponsor convince regulators to allow development to proceed? Pharmacol Ther. 2008;119(2):215–21.
Article CAS PubMed Google Scholar
Weibel S, Rücker G, Eberhart LH, et al. Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis. Cochrane Database Syst Rev. 2020;10(10):Cd012859.
Kienbaum P, Schaefer MS, Weibel S, et al. Update on PONV-What is new in prophylaxis and treatment of postoperative nausea and vomiting?: summary of recent consensus recommendations and cochrane reviews on prophylaxis and treatment of postoperative nausea and vomiting. Anaesthesist. 2022;71(2):123–8.
Article CAS PubMed Google Scholar
Brygger L, Herrstedt J. 5-Hydroxytryptamine3 receptor antagonists and cardiac side effects. Expert Opin Drug Saf. 2014;13(10):1407–22.
Article CAS PubMed Google Scholar
Buyukavci M, Olgun H, Ceviz N. The effects of ondansetron and granisetron on electrocardiography in children receiving chemotherapy for acute leukemia. Am J Clin Oncol. 2005;28(2):201–4.
Article CAS PubMed Google Scholar
Tricco AC, Blondal E, Veroniki AA, et al. Comparative safety and effectiveness of serotonin receptor antagonists in patients undergoing chemotherapy: a systematic review and network meta-analysis. BMC Med. 2016;14(1):216.
Article PubMed PubMed Central Google Scholar
Bennett K, Cahir C, Sorensen J. Costs associated with adverse drug reactions in an older population admitted to hospital: a prospective cohort study. Eur J Clin Pharmacol. 2023;79(10):1417–24.
Article PubMed PubMed Central Google Scholar
Rochoy M, Auffret M, BéNé J, et al. Antiemetics and cardiac effects potentially linked to prolongation of the QT interval: case/non-case analysis in the national pharmacovigilance database. Rev Epidemiol Sante Publique. 2017;65(1):1–8.
Article CAS PubMed Google Scholar
Ritchie HE, Huss IB, Webster WS. The effect of anti-emetic drugs on rat embryonic heart activity. Reprod Toxicol. 2019;87:140–5.
Article CAS PubMed Google Scholar
de Lorenzi FG, Bridal TR, Spinelli W. Block of the delayed rectifier current (IK) by the 5-HT3 antagonists ondansetron and granisetron in feline ventricular myocytes. Br J Pharmacol. 1994;113(2):527–35.
Article PubMed PubMed Central Google Scholar
Cakir FB, Yapar O, Canpolat C, et al. Cardiac effects of granisetron in a prospective crossover randomized dose comparison trial. Support Care Cancer. 2012;20(10):2451–7.
Article CAS PubMed Google Scholar
Iasonos A, Schrag D, Raj GV, et al. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364–70.
Wang L, Yang L, Li T, et al. Development and validation of nomogram for the prediction of malignant ventricular arrhythmia including circulating inflammatory cells in patients with acute ST-segment elevation myocardial infarction. J Inflamm Res. 2023;16:3185–96.
Article PubMed PubMed Central Google Scholar
Guo H, Guo D, Gao A, et al. Establishment and validation of automatic monitoring module for drug-induced arrhythmia based on data of HIS. Chin J Drug Appl Monit. 2022;19(3):176–81.
Mavroudis C, Stulak JM, Ad N, et al. Prophylactic atrial arrhythmia surgical procedures with congenital heart operations: review and recommendations. Ann Thorac Surg. 2015;99(1):352–9.
Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–45.
Article CAS PubMed Google Scholar
Peduzzi P, Concato J, Kemper E, et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49(12):1373–9.
Article CAS PubMed Google Scholar
Chen C, Jia W, Guo D, et al. Development of a computer-assisted adverse drug events alarm and assessment system for hospital inpatients in China. Ther Innov Regul Sci. 2020;54(1):32–41.
Costa C, Abeijon P, Rodrigues DA, et al. Factors associated with underreporting of adverse drug reactions by patients: a systematic review. Int J Clin Pharm. 2023;45(6):1349–58.
Article PubMed PubMed Central Google Scholar
Reiffel JA. Propensity score matching: the “devil is in the details” where more may be hidden than you know. Am J Med. 2020;133(2):178–81.
Tricco AC, Soobiah C, Blondal E, et al. Comparative safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery: a systematic review and network meta-analysis. BMC Med. 2015;13:142.
Article PubMed PubMed Central Google Scholar
Mason JW, Selness DS, Moon TE, et al. Pharmacokinetics and repolarization effects of intravenous and transdermal granisetron. Clin Cancer Res. 2012;18(10):2913–21.
Article CAS PubMed Google Scholar
Raftopoulos H, Cooper W, O’Boyle E, et al. Comparison of an extended-release formulation of granisetron (APF530) versus palonosetron for the prevention of chemotherapy-induced nausea and vomiting associated with moderately or highly emetogenic chemotherapy: results of a prospective, randomized, double-blind, noninferiority phase 3 trial. Support Care Cancer. 2015;23(3):723–32.
Savant K, Khandeparker RV, Berwal V, et al. Comparison of ondansetron and granisetron for antiemetic prophylaxis in maxillofacial surgery patients receiving general anesthesia: a prospective, randomised, and double blind study. J Korean Assoc Oral Maxillofac Surg. 2016;42(2):84–9.
Article PubMed PubMed Central Google Scholar
Kleiber N, Gariépy-Assal L, Coulombe J, et al. Off-label use and safety of drug use in vascular anomalies. Dermatology. 2021;237(4):649–57.
Article CAS PubMed Google Scholar
Tisdale JE, Jaynes HA, Kingery JR, et al. Development and validation of a risk score to predict QT interval prolongation in hospitalized patients. Circ Cardiovasc Qual Outcomes. 2013;6(4):479–87.
Article PubMed PubMed Central Google Scholar
Ma M, Zhi H, Yang S, et al. Body mass index and the risk of atrial fibrillation: a mendelian randomization study. Nutrients. 2022;14(9):1878.
Article PubMed PubMed Central Google Scholar
Jupiter DC. Propensity score matching: retrospective randomization? J Foot Ankle Surg. 2017;56(2):417–20.
Zeltser D, Justo D, Halkin A, et al. Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors. Medicine. 2003;82(4):282–90.
FDA Drug Safety Communication: Updated information on 32 mg intravenous ondansetron (Zofran) dose and pre-mixed ondansetron products. 2012.
Prasad M, Shashidar VK, Chakraborty A. Palonosetron-induced ventricular tachycardia in a patient receiving cancer chemotherapy. Cureus. 2017;9(7):e1480.
Wolf H. Preclinical and clinical pharmacology of the 5-HT3 receptor antagonists. Scand J Rheumatol Suppl. 2000;113:37–45.
Article CAS PubMed Google Scholar
Geurts S, van der Burgh AC, Bos MM, et al. Disentangling the association between kidney function and atrial fibrillation: a bidirectional mendelian randomization study. Int J Cardiol. 2022;355:15–22.
Liu EQ, Zeng CL. Blood urea nitrogen and in-hospital mortality in critically Ill patients with cardiogenic shock: analysis of the MIMIC-III database. Biomed Res Int. 2021;2021:5948636.
PubMed PubMed Central Google Scholar
Yu C, Guo D, Yao C, et al. Development and validation of a nomogram for predicting drug-induced acute kidney injury in hospitalized patients: a case-control study based on propensity-score matching. Front Pharmacol. 2021;12:657853.
Comments (0)